Medical and Clinical Aspects of Cannabis

Process and Practicalities of Medical Cannabis in Canada

Danial Schechter, M.D., CCFP

Cannabinoids and Neurological Conditions

Colleen O’Connell, M.D., FRCPC

Cannabis and Pregnancy: Up in Smoke

Jocelynn Cook, PhD, MBA

Is there research on cannabis use by males who want to conceive?

Is there research addressing dose, dose dependency and trimester of consumption?

Should we distinguish between THC and CBD when talking about cannabis use during pregnancy?

Use of Cannabinoids in Older Persons

David Lussier, MD, FRCPC

What were the doses used in the Israeli and rodent studies? Are they comparable?

Allosteric Modulation of the Type 1 Cannabinoid Receptor for the Treatment of Huntington’s Disease

Robert LaPrairie, PhD

Do allosteric modulators not lead to receptor down regulation or change in receptor pool?

When you are developing the allosteric modulators, do you ever see cross-talk with the CB2 receptors?

Cannabinoids in the Hospital and Long Term Care Setting

Danial Schecter, MD, CCFP

Do you prescribe cannabinoids for palliative care patients? If so, what has your experience been like?

Have you ever created education and/or a support system for nurses and other staff on medical cannabis?

What are the risks of combining cannabis with Noax for patients who have atrial fibrillation?

Did you make a full cannabinoid policy at the hospital? Would you be willing to share it?

Can patients cross the border with Sativex and Cesamet?

Is there a minimum THC level that you would even bother converting to Nabilone?

Challenging Patient Cases: Clinical vs. Science of Cannabis Chemovars

Caroline MacCallum, MD, FRCPC

Effects of Recreational Cannabis Use on Brain Structure

Kent Hutchison, Ph.D.

Cannadidiol as a Treatment for Opiate Dependence?

Yasmin Hurd, Ph.D.

Role of the Expanded Endocannabinoid System in Cardiometabolic Risk

Cristoforo Silvestri, PhD

What causes the dysregulation of the endocannabinoid system?

Opioid Sparing Effects of Cannabinoids: Myth or Reality?

Bernard Le Foll, MD, PhD, MCFP

Are you aware of any literature that addresses easing opioid withdrawal symptoms with cannabis?

Where should we invest our research efforts with regards to the opioid sparing effects of cannabinoids?